AVI BioPharma Announces 2007 Fourth Quarter and Year End Financial Results Conference Call.PORTLAND, Ore. -- AVI BioPharma Inc. (Nasdaq:AVII) today announced that the company will hold a conference call to discuss its 2007 fourth quarter and full year financial results on Wednesday, March 12, 2008, at 11:00 a.m. Eastern time (8:00 a.m. Pacific time). Individuals interested in listening to the live conference call may do so by dialing (888) 803-8271 toll free within the United States and Canada, or (706) 634-2467 for international callers. A telephone replay of the conference call will be available for 48 hours, beginning two hours after the conclusion of the call, by dialing (800) 642-1687 domestically, or (706) 645-9291 internationally, and entering reservation number 38222923. The conference call can be heard live via audio webcast at the company's Web site: www.avibio.com. A webcast replay will be available for 14 days. About AVI BioPharma AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE([R]) antisense drugs and ESPRIT exon Exon In split genes, a portion that is included in the ribonucleic acid (RNA) transcript of a gene and survives processing of the RNA in the cell nucleus to become part of a spliced messenger RNA (mRNA) or structural RNA in the cell cytoplasm. skipping technology. AVI's ESPRIT technology is initially being applied to potential treatments for Duchenne muscular dystrophy Duchenne muscular dystrophy (DMD) The most severe form of muscular dystrophy, DMD usually affects young boys and causes progressive muscle weakness, usually beginning in the legs. . AVI's NEUGENE compounds are also designed to treat cardiovascular restenosis, and aid in coronary artery bypass graft coronary artery bypass graft n. Abbr. CABG A surgical procedure in which a section of vein or other conduit is grafted between the aorta and a coronary artery below the region of an obstruction in that artery. (CABG CABG coronary artery bypass graft. CABG abbr. coronary artery bypass graft CABG Coronary artery bypass graft, see there ) procedures. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including Marburg virus, Ebola Zaire virus, and H5N1 avian influenza virus. More information about AVI (Audio Video Interleaved) A Windows multimedia video format from Microsoft. It interleaves standard waveform audio and digital video frames (bitmaps) to provide reduced animation at 15 fps at 160x120x8 resolution. Audio is 11,025Hz, 8-bit samples. is available on the company's Web site at http://www.avibio.com. "Safe Harbor" Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: The statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties, including, but not limited to, the results of research and development efforts, the results of preclinical and clinical testing, the effect of regulation by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the company's Securities and Exchange Commission filings. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion